New antidepressants: monoamines and beyond
نویسندگان
چکیده
The monoamine hypothesis of depression has dominated treatment for decades, but some with treatment-resistant depression, alternative approaches are needed. This article discusses the other mechanisms involved in and how novel treatments could address these.
منابع مشابه
Beyond Ketamine: New Approaches to the Development of Safer Antidepressants
BACKGROUND Ketamine has been reported to exert rapid and sustained antidepressant effects in patients with depression, including patients with treatment-resistant depression. However, ketamine has several drawbacks such as psychotomimetic/dissociative symptoms, abuse potential and neurotoxicity, all of which prevent its routine use in daily clinical practice. METHODS Therefore, development of...
متن کاملDevelopment of new antidepressants
The development of the first effective antidepressants in the late 1950s marked a turning point in the treatment of depressive illness. In 1957 the monoamine oxidase inhibitor (MAOI) iproniazid was discovered by chance, while searching for new antituberculous drugs. One year later the tricyclic antidepressant (TCA) imipramine was introduced, having been developed originally as an antipsychotic....
متن کاملNew antidepressants in pregnancy.
QUESTION I have read that fluoxetine is the drug of choice for treating depression during pregnancy. One of my patients, who did not respond to the "old" selective serotonin reuptake inhibitors, is doing well on venlafaxine and is now 6 weeks pregnant. What advice should I give her? ANSWER Fluoxetine is recommended because to date it has the most evidence of its safety. It is important that w...
متن کاملNovel antidepressants and panic disorder: evidence beyond current guidelines.
AIM The aim of the present review is to summarize available evidence about the efficacy and side effects of novel antidepressants for the treatment of panic disorder. METHODS A literature search was undertaken using MEDLINE, ISI web of knowledge and references of retrieved articles. The search included articles published in English up to September 2009. Both controlled and uncontrolled trials...
متن کاملRapid-acting glutamatergic antidepressants: the path to ketamine and beyond.
Traditional antidepressants require many weeks to reveal their therapeutic effects. However, the widely replicated observation that a single subanesthetic dose of the N-methyl-D-aspartate glutamate receptor antagonist ketamine produced meaningful clinical improvement within hours, suggested that rapid-acting antidepressants might be possible. The ketamine studies stimulated a new generation of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Prescriber
سال: 2023
ISSN: ['0959-6682', '1931-2253']
DOI: https://doi.org/10.1002/psb.2032